Transdermal device having a phase change material

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040191301A1
SERIAL NO

10402023

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A transdermal device contains a phase change material and another material. The transdermal device may also contain a drug, a pharmaceutical, or a medicament mixed with or disposed near the phase change material. The phase change material transitions from solid to liquid form when heated. The other material is disposed, suspended, or held in the phase change material when the phase change material is in its solid form. When heat is applied to the transdermal device, the phase change material changes to a liquid state and the material that is held or suspended in the phase change material is released. Advantageously, such materials may include substances such as pharmaceuticals that boost or supplement the effect produced by a drug delivered transdermally by the device, or drug antagonists.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARIZANT HEALTHCARE INC10393 WEST 70TH STREET EDEN PRAIRIE MN 55344

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Van, Duren Albert Philip Chaska, MN 9 110

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation